In advance of this manuscript, you might also see this manuscript from our team using similar intraoperative 3D printing (biodressing) technology
In an intriguing study published in the Archives of Plastic Surgery, researchers Hyeonmin Yoon and Woojin Song have continued with a novel approach to limb salvage in the treatment of diabetic foot ulcers (DFUs) through the use of 3D-bioprinted autologous minimally manipulated homologous adipose tissue (3D-AMHAT). This innovative technique represents a significant advancement in the field of reconstructive surgery, offering a promising alternative for patients who are unsuitable for traditional flap reconstruction due to various comorbidities.
The study details the case of a 78-year-old female patient with a non-healing DFU, complicated by renal failure and severe peripheral arterial disease (PAD). Initially recommended for amputation due to extensive necrosis and osteomyelitis, the patient’s strong preference for limb salvage led the team to consider an alternative approach. The decision to utilize 3D-AMHAT for reconstructing the patient’s foot marked a pivotal moment in diabetic foot care, demonstrating the potential of this technology to significantly impact patient outcomes positively.
The successful engraftment of the 3D-AMHAT without complications such as autolysis, graft failure, or infection, and the subsequent reduction in wound size, underscores the viability of this method as a treatment option. The patient’s wound decreased to less than half its original size after 6 weeks of surgery and further reduced to less than 25% after 12 weeks, showcasing the effectiveness of 3D-AMHAT in promoting wound healing and potentially preventing amputation.
This study not only highlights the innovative use of 3D bioprinting technology in the treatment of DFUs but also emphasizes the importance of patient-centered care in the decision-making process. By opting for a limb salvage procedure that aligned with the patient’s preferences, Yoon and Song have set a precedent for the integration of advanced technologies in personalized healthcare solutions.
The successful application of 3D-AMHAT in this case opens new avenues for research and clinical practice, suggesting that this technique could be an appealing treatment option for diabetic foot patients who are unsuitable for traditional reconstructive methods. As the field of plastic and reconstructive surgery continues to evolve, the work of Yoon and Song serves as a beacon of innovation, offering hope to patients facing the daunting prospect of amputation due to DFUs.
Citations:
DOI: 10.1055/a-2263-7957
Leave a Reply